增强的葡萄糖调节潜力模仿C-的C-
Alpana Boruah1,2, Nazim Uddin Afzal2,3, Sayari Saha1
1Chemical Sciences and Technology Division, CSIR - North East Institute of Science and Technology (CSIR-NEIST), Pulibor, Jorhat-785006, Assam, India. aroy@neist.res.in.
Organic & biomolecular chemistry
|May 1, 2025
概括
合成的C-仿真体对糖尿病研究有前途. 一种仿真剂,CP8,改善了葡萄糖代谢,减少了氧化应激,作用类似于胰岛素.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 内分泌学 在内分泌学.
背景情况:
- 连接 (C-) 以其激素活性和在管理糖尿病相关并发症中的作用而闻名.
- C-作为β细胞功能的生物标志物,其半衰期比胰岛素更长.
- C-会影响亲胰岛素的处理,并表现出细胞的反应性.
研究的目的:
- 为了研究合成C-模仿剂对葡萄糖恒温的作用.
- 为了评估葡萄糖吸收,GLUT4转位和膜贩运.
- 评估C-模仿剂作为糖尿病治疗剂的潜力.
主要方法:
- 利用L6肌肉髓管测试合成C-模仿物.
- 测量葡萄糖利用,GLUT4转位和相关的膜贩运.
- 评估了Akt酸化,IRβ自酸化和反应性氧物种的产生.
主要成果:
- 与人类C-相比,一些C-仿真体在L6神经管中显示出更高的葡萄糖利用率.
- CP8表现出类似胰岛素的葡萄糖代谢,包括Akt和IRβ酸化.
- CP8减轻了分子内活性氧物种的产生.
结论:
- 合成的C-仿真体显示出增强葡萄糖代谢的潜力.
- CP8显示了与Akt和IRβ的有希望的相互作用,表明了治疗潜力.
- 模仿C-是未来糖尿病研究和开发的有希望的候选人.
相关概念视频
Glucagon-like Receptor Agonists
250
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
250
Cell Specific Gene Expression
13.3K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.3K
Dipeptidyl Peptidase 4 Inhibitors
117
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
117
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.0K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.0K
Hormones Regulating Blood Glucose
2.9K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
2.9K
Oral Hypoglycemic Agents: Glinides
109
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
109


